Opthea Limited (ASX:OPT)
0.600
0.00 (0.00%)
Mar 14, 2025, 4:10 PM AEST
Opthea Revenue
Opthea had revenue of $667.00 USD in the half year ending December 31, 2025, a decrease of -99.67%. This brings the company's revenue in the last twelve months to $-13.42K, down -106.43% year-over-year. In the fiscal year ending June 30, 2025, Opthea had annual revenue of $146.00K, down -44.27%.
Revenue (ttm)
$-13.42K
Revenue Growth
-106.43%
P/S Ratio
-36,723.76
Revenue / Employee
$-406.61
Employees
33
Market Cap
738.77M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 146.00K | -116.00K | -44.27% |
| Jun 30, 2024 | 262.00K | -123.28K | -32.00% |
| Jun 30, 2023 | 385.28K | 186.27K | 93.60% |
| Jun 30, 2022 | 199.01K | 103.44K | 108.24% |
| Jun 30, 2021 | 95.56K | -5.13K | -5.09% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Immutep | 7.92M |
| Clinuvel Pharmaceuticals | 96.30M |
| Racura Oncology | 3.48M |
| Clarity Pharmaceuticals | 10.58M |
| PYC Therapeutics | 20.56M |
| Neuren Pharmaceuticals | 64.65M |
| Dimerix | 7.42M |
| Orthocell | 9.33M |
Opthea News
- 7 months ago - Opthea Provides Corporate Update - GlobeNewsWire
- 1 year ago - Opthea Announces Decision to Discontinue Wet AMD Trials - GlobeNewsWire
- 1 year ago - Opthea Announces COAST Phase 3 Trial Topline Results - GlobeNewsWire
- 1 year ago - Opthea Announces Phase 2b Wet AMD Publication - GlobeNewsWire
- 1 year ago - Opthea to Present at Oppenheimer Healthcare Conference - GlobeNewsWire
- 1 year ago - Opthea Wet AMD Data Featured at Macula Society Meeting - GlobeNewsWire
- 1 year ago - Opthea to Host Investor Days in New York and Australia - GlobeNewsWire
- 1 year ago - Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire